back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-02 14:28 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aries Biologics (Control or Direction)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$35,750
+55,000 vol $0.65 each |
55,000 | |
| Filed 2026-06-02 14:27 Tx date 2017-03-01 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aries Biologics (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-02 14:27 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Merchant, Fahar
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Aries Biologics (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$55,000
+110,000 vol $0.50 each |
5,610,000 | |
| Filed 2026-06-02 14:14 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$130,000
+200,000 vol $0.65 each |
200,000 | |
| Filed 2026-06-02 14:13 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Beraldo, Albert George
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,000
+400,000 vol $0.50 each |
880,113 | |
| Filed 2026-06-02 14:11 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Georgakis, Angelos
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$6,500
+10,000 vol $0.65 each |
10,000 | |
| Filed 2026-06-02 14:10 Tx date 2026-02-12 |
$MDNA
Medicenna Therapeutics Corp. |
Georgakis, Angelos
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-02 14:09 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Georgakis, Angelos
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$10,000
+20,000 vol $0.50 each |
20,000 | |
| Filed 2026-06-02 14:07 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Sutin, Richard S.
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$6,500
+10,000 vol $0.65 each |
10,000 | |
| Filed 2026-06-02 14:01 Tx date 2026-02-12 |
$MDNA
Medicenna Therapeutics Corp. |
Sutin, Richard S.
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-02 13:57 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Sutin, Richard S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$10,000
+20,000 vol $0.50 each |
23,000 | |
| Filed 2026-06-02 10:31 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+25,000 vol |
25,000 | |
| Filed 2026-06-02 10:30 Tx date 2024-01-15 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-02 10:28 Tx date 2026-05-28 |
$MDNA
Medicenna Therapeutics Corp. |
Hyman, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$2,500
+50,000 vol $0.05 each |
100,000 | |
| Filed 2026-04-20 15:44 Tx date 2026-04-09 |
$MDNA
Medicenna Therapeutics Corp. |
Ibrahim, Nageatte
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-09 15:26 Tx date 2026-03-05 |
$MDNA
Medicenna Therapeutics Corp. |
Sutin, Richard S.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+63,000 vol |
63,000 | |
| Filed 2026-03-09 15:25 Tx date 2026-02-12 |
$MDNA
Medicenna Therapeutics Corp. |
Sutin, Richard S.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-09 15:22 Tx date 2026-03-05 |
$MDNA
Medicenna Therapeutics Corp. |
Georgakis, Angelos
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+63,000 vol |
63,000 | |
| Filed 2026-03-09 15:21 Tx date 2026-02-12 |
$MDNA
Medicenna Therapeutics Corp. |
Georgakis, Angelos
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-02-23 14:23 Tx date 2026-02-23 |
$MDNA
Medicenna Therapeutics Corp. |
Sutin, Richard S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,940
+3,000 vol $0.98 each |
3,000 |